ORAMED PHARMACEUTICALS INC. Quarterly Current Ratio in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Oramed Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q2 2012 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Current Ratio for the quarter ending June 30, 2024 was 396 %, a 88.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 396 -3.01K -88.4% Jun 30, 2024
Q1 2024 401 -2.17K -84.4% Mar 31, 2024
Q4 2023 469 -1.91K -80.3% Dec 31, 2023
Q3 2023 710 -1.49K -67.7% Sep 30, 2023
Q2 2023 3.4K +1.46K +74.8% Jun 30, 2023
Q1 2023 2.57K +809 +46% Mar 31, 2023
Q4 2022 2.38K +932 +64.3% Dec 31, 2022
Q3 2022 2.2K +1.12K +103% Sep 30, 2022
Q2 2022 1.95K +1.01K +107% Jun 30, 2022
Q1 2022 1.76K +896 +104% Mar 31, 2022
Q4 2021 1.45K +697 +92.5% Dec 31, 2021
Q3 2021 1.08K +314 +40.8% Aug 31, 2021
Q2 2021 939 +238 +34% May 31, 2021
Q1 2021 862 +270 +45.7% Feb 28, 2021
Q4 2020 753 +160 +26.9% Nov 30, 2020
Q3 2020 769 +167 +27.8% Aug 31, 2020
Q2 2020 701 +87 +14.2% May 31, 2020
Q1 2020 591 +6.04 +1.03% Feb 29, 2020
Q4 2019 593 +40.7 +7.36% Nov 30, 2019
Q3 2019 602 +128 +27.1% Aug 31, 2019
Q2 2019 614 +206 +50.6% May 31, 2019
Q1 2019 585 +152 +35% Feb 28, 2019
Q4 2018 553 +80.9 +17.2% Nov 30, 2018
Q3 2018 474 -64.5 -12% Aug 31, 2018
Q2 2018 408 -236 -36.6% May 31, 2018
Q1 2018 434 -364 -45.6% Feb 28, 2018
Q4 2017 472 -535 -53.2% Nov 30, 2017
Q3 2017 538 -716 -57.1% Aug 31, 2017
Q2 2017 643 -839 -56.6% May 31, 2017
Q1 2017 798 -697 -46.7% Feb 28, 2017
Q4 2016 1.01K -630 -38.5% Nov 30, 2016
Q3 2016 1.25K -849 -40.4% Aug 31, 2016
Q2 2016 1.48K -1.1K -42.6% May 31, 2016
Q1 2016 1.49K -1.28K -46.2% Feb 29, 2016
Q4 2015 1.64K -1.61K -49.6% Nov 30, 2015
Q3 2015 2.1K -689 -24.7% Aug 31, 2015
Q2 2015 2.58K -215 -7.67% May 31, 2015
Q1 2015 2.78K +478 +20.8% Feb 28, 2015
Q4 2014 3.25K +1.93K +147% Nov 30, 2014
Q3 2014 2.79K +1.29K +86.2% Aug 31, 2014
Q2 2014 2.8K +1.59K +132% May 31, 2014
Q1 2014 2.3K +1.17K +103% Feb 28, 2014
Q4 2013 1.32K +395 +42.9% Nov 30, 2013
Q3 2013 1.5K +767 +105% Aug 31, 2013
Q2 2013 1.21K +446 +58.6% May 31, 2013
Q1 2013 1.14K Feb 28, 2013
Q4 2012 921 Nov 30, 2012
Q3 2012 733 Aug 31, 2012
Q2 2012 760 May 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.